This study proposes that the inflammation-GHRL/MSTN-appetite improvement/muscle growth-CHF improvement pathway may be a key regulatory mechanism in the development of malnutrition and muscle loss in CHF patients,which represents a promising direction for research into the mechanisms of malnutrition and muscle loss disorders in patients with CHF. The gene discussed is MSTN; the disease is malnutrition.